stars 1 stars 2 stars 3

IMcoMET is a MedTech startup. We have developed a technology, called the M-Duo Technology®, that allows access and control of fluid around cells, called interstitial fluid. This fluid contains many biomarkers that provide detailed information about both the local tissue condition and general health status of an individual. We are integrating our M-Duo Technology® into a set of tools to improve skin diagnostics and research to drive personalized medicine and biomedical research forward. Both with the ultimate goal to improve therapy outcomes for patients with inflammatory skin diseases.

IMcoMET Questions

Martin Bakker is the Director of Business Development of IMcoMET.

3 people are employed at IMcoMET.

Top IMcoMET Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users